Janssen Pharmaceuticals Inc.

09/19/2021 | Press release | Distributed by Public on 09/19/2021 13:09

New Data on RYBREVANT® (amivantamab-vmjw) in Combination with Lazertinib Show Early Activity in Patients with Non-Small Cell Lung Cancer Whose Disease Has Progressed After Both[...]